Optical coherence tomography in alzheimer’s disease

Gianluca Coppola, Vincenzo Parisi, Gianluca Manni, Francesco Pierelli, Alfredo A. Sadun

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Alzheimer’s disease (AD) is a neurodegenerative disorder, which is likely to start as mild cognitive impairment (MCI) several years before its fullblown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to observe a signifi cant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests. Furthermore, these structural measures correlate with electrophysiological parameters of pattern electroretinogram, refl ecting integrity of the innermost retinal layers, but not with those of the visual evoked potentials, refl ecting activity of the post-chiasmatic visual pathway. The latter evidence suggests that RNFL thickness reduction is related to neuronal degeneration in the ganglion cell layer and not to a retrograde degeneration from the post-chiasmatic visual pathway. These data suggest a possible role of OCT in monitoring the progression of AD and in assessing the effectiveness of purported AD treatments.

Original languageEnglish
Title of host publicationOCT in Central Nervous System Diseases: The Eye as a Window to the Brain
PublisherSpringer International Publishing
Pages123-142
Number of pages20
ISBN (Electronic)9783319240855
ISBN (Print)9783319240831
DOIs
Publication statusPublished - Jan 1 2016

Fingerprint

Optical tomography
Optical Coherence Tomography
Alzheimer Disease
Visual Pathways
Nerve Fibers
Retrograde Degeneration
Visual Evoked Potentials
Neuropsychological Tests
Ganglia
Neurodegenerative Diseases
Dementia
Fibers
Bioelectric potentials
Cells
Monitoring
Therapeutics

Keywords

  • Alzheimer’s disease
  • Electroretinogram
  • Mild cognitive impairment
  • Optical coherence tomography
  • Psychometric testing
  • Retina

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Coppola, G., Parisi, V., Manni, G., Pierelli, F., & Sadun, A. A. (2016). Optical coherence tomography in alzheimer’s disease. In OCT in Central Nervous System Diseases: The Eye as a Window to the Brain (pp. 123-142). Springer International Publishing. https://doi.org/10.1007/978-3-319-24085-5_7

Optical coherence tomography in alzheimer’s disease. / Coppola, Gianluca; Parisi, Vincenzo; Manni, Gianluca; Pierelli, Francesco; Sadun, Alfredo A.

OCT in Central Nervous System Diseases: The Eye as a Window to the Brain. Springer International Publishing, 2016. p. 123-142.

Research output: Chapter in Book/Report/Conference proceedingChapter

Coppola, G, Parisi, V, Manni, G, Pierelli, F & Sadun, AA 2016, Optical coherence tomography in alzheimer’s disease. in OCT in Central Nervous System Diseases: The Eye as a Window to the Brain. Springer International Publishing, pp. 123-142. https://doi.org/10.1007/978-3-319-24085-5_7
Coppola G, Parisi V, Manni G, Pierelli F, Sadun AA. Optical coherence tomography in alzheimer’s disease. In OCT in Central Nervous System Diseases: The Eye as a Window to the Brain. Springer International Publishing. 2016. p. 123-142 https://doi.org/10.1007/978-3-319-24085-5_7
Coppola, Gianluca ; Parisi, Vincenzo ; Manni, Gianluca ; Pierelli, Francesco ; Sadun, Alfredo A. / Optical coherence tomography in alzheimer’s disease. OCT in Central Nervous System Diseases: The Eye as a Window to the Brain. Springer International Publishing, 2016. pp. 123-142
@inbook{12f1a8bed97949a48148854cf1da2b9d,
title = "Optical coherence tomography in alzheimer’s disease",
abstract = "Alzheimer’s disease (AD) is a neurodegenerative disorder, which is likely to start as mild cognitive impairment (MCI) several years before its fullblown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to observe a signifi cant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests. Furthermore, these structural measures correlate with electrophysiological parameters of pattern electroretinogram, refl ecting integrity of the innermost retinal layers, but not with those of the visual evoked potentials, refl ecting activity of the post-chiasmatic visual pathway. The latter evidence suggests that RNFL thickness reduction is related to neuronal degeneration in the ganglion cell layer and not to a retrograde degeneration from the post-chiasmatic visual pathway. These data suggest a possible role of OCT in monitoring the progression of AD and in assessing the effectiveness of purported AD treatments.",
keywords = "Alzheimer’s disease, Electroretinogram, Mild cognitive impairment, Optical coherence tomography, Psychometric testing, Retina",
author = "Gianluca Coppola and Vincenzo Parisi and Gianluca Manni and Francesco Pierelli and Sadun, {Alfredo A.}",
year = "2016",
month = "1",
day = "1",
doi = "10.1007/978-3-319-24085-5_7",
language = "English",
isbn = "9783319240831",
pages = "123--142",
booktitle = "OCT in Central Nervous System Diseases: The Eye as a Window to the Brain",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Optical coherence tomography in alzheimer’s disease

AU - Coppola, Gianluca

AU - Parisi, Vincenzo

AU - Manni, Gianluca

AU - Pierelli, Francesco

AU - Sadun, Alfredo A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - Alzheimer’s disease (AD) is a neurodegenerative disorder, which is likely to start as mild cognitive impairment (MCI) several years before its fullblown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to observe a signifi cant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests. Furthermore, these structural measures correlate with electrophysiological parameters of pattern electroretinogram, refl ecting integrity of the innermost retinal layers, but not with those of the visual evoked potentials, refl ecting activity of the post-chiasmatic visual pathway. The latter evidence suggests that RNFL thickness reduction is related to neuronal degeneration in the ganglion cell layer and not to a retrograde degeneration from the post-chiasmatic visual pathway. These data suggest a possible role of OCT in monitoring the progression of AD and in assessing the effectiveness of purported AD treatments.

AB - Alzheimer’s disease (AD) is a neurodegenerative disorder, which is likely to start as mild cognitive impairment (MCI) several years before its fullblown clinical manifestation. In the last two decades, optical coherence tomography (OCT) has been used to observe a signifi cant loss in peripapillary retinal nerve fiber layer (RNFL) and in macular thickness and volume in patients affected by a form of mild to severe dementia. These morphological abnormalities correlate to some extent with the severity of the disease as evaluated with neuropsychological tests. Furthermore, these structural measures correlate with electrophysiological parameters of pattern electroretinogram, refl ecting integrity of the innermost retinal layers, but not with those of the visual evoked potentials, refl ecting activity of the post-chiasmatic visual pathway. The latter evidence suggests that RNFL thickness reduction is related to neuronal degeneration in the ganglion cell layer and not to a retrograde degeneration from the post-chiasmatic visual pathway. These data suggest a possible role of OCT in monitoring the progression of AD and in assessing the effectiveness of purported AD treatments.

KW - Alzheimer’s disease

KW - Electroretinogram

KW - Mild cognitive impairment

KW - Optical coherence tomography

KW - Psychometric testing

KW - Retina

UR - http://www.scopus.com/inward/record.url?scp=84978289497&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978289497&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-24085-5_7

DO - 10.1007/978-3-319-24085-5_7

M3 - Chapter

AN - SCOPUS:84978289497

SN - 9783319240831

SP - 123

EP - 142

BT - OCT in Central Nervous System Diseases: The Eye as a Window to the Brain

PB - Springer International Publishing

ER -